atenolol has been researched along with berotek in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (45.83) | 18.7374 |
| 1990's | 3 (12.50) | 18.2507 |
| 2000's | 5 (20.83) | 29.6817 |
| 2010's | 3 (12.50) | 24.3611 |
| 2020's | 2 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
| Acevedo, O; Dasararaju, G; Devadasan, V; Halakova, D; Jayaprakash, V; Kovacikova, L; Mohd Siddique, MU; Mondal, SK; Prnova, MS; Shilkar, D; Stefek, M; Thakur, A; Yasmin, S | 1 |
| Chin, JP; Pennefather, JN | 1 |
| Chapman, KR; Galko, BM; Leenen, FH; Smith, DL | 1 |
| Aoki, K; Dohi, Y; Fujimoto, S; Matsuda, T | 1 |
| O'Donnell, SR; Wanstall, JC | 4 |
| Hartley, ML; Pennefather, JN | 1 |
| Arnaud, A; Bruguerolle, B; Philip-Joet, F; Saadjian, A | 1 |
| Malta, E; Mian, MA; Raper, C | 1 |
| Hughes, JM; Seale, JP; Temple, DM | 1 |
| Diemer, HP; Heidenreich, J; Poleska, W; Schmidt, H; Steyer, M | 1 |
| Lipworth, BJ; McDevitt, DG; Newnham, DM; Wheeldon, NM | 1 |
| Beasley, R; Burgess, C; Crane, J; Wong, C | 1 |
| Horinouchi, T; Koike, K; Nakagawa, Y; Wakabayashi, M | 1 |
| Baeyens, WR; De Beer, T; Dilinuer, M; Fei, GT; Ouyang, J; Wang, Y; Zhou, S | 1 |
| Brockmöller, J; Jensen, O; Rafehi, M; Tzvetkov, MV | 1 |
3 trial(s) available for atenolol and berotek
| Article | Year |
|---|---|
Effects of atenolol vs diltiazem on the haemodynamic effects of an inhaled beta 2-adrenoceptor agonist.
Topics: Adult; Atenolol; Blood Pressure; Cardiac Output; Diltiazem; Echocardiography; Fenoterol; Heart Rate; Hemodynamics; Humans; Male; Vascular Resistance | 1989 |
Comparative study of the respiratory effects of two beta 1-selective blocking agents atenolol and bevantolol in asthmatic patients.
Topics: Adrenergic beta-Antagonists; Adult; Asthma; Atenolol; Clinical Trials as Topic; Double-Blind Method; Female; Fenoterol; Forced Expiratory Volume; Heart Rate; Humans; Male; Peak Expiratory Flow Rate; Propanolamines; Random Allocation; Respiration; Time Factors | 1986 |
Single dosing comparison of the relative cardiac beta 1/beta 2 activity of inhaled fenoterol and salbutamol in normal subjects.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Adult; Albuterol; Atenolol; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Fenoterol; Heart; Heart Rate; Humans; Male; Potassium; Receptors, Adrenergic, beta | 1993 |
21 other study(ies) available for atenolol and berotek
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
Non-carboxylic acid inhibitors of aldose reductase based on N-substituted thiazolidinedione derivatives.
Topics: Aldehyde Reductase; Animals; Caco-2 Cells; Catalytic Domain; Dogs; Enzyme Inhibitors; Humans; Hypoglycemic Agents; Madin Darby Canine Kidney Cells; Male; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Structure; Protein Binding; Rats, Wistar; Structure-Activity Relationship; Thiazolidinediones | 2021 |
Classification of the beta-adrenoceptor subtype in the rat portal vein: effect of altered thyroid hormone levels.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Fenoterol; Heart Rate; In Vitro Techniques; Male; Norepinephrine; Portal Vein; Propanolamines; Radioimmunoassay; Radioligand Assay; Rats; Receptors, Adrenergic, beta; Thyroid Hormones | 1992 |
Altered vascular beta adrenoceptor-mediated relaxation in deoxycorticosterone-salt hypertensive rats.
Topics: Animals; Atenolol; Bucladesine; Butoxamine; Desoxycorticosterone; Fenoterol; Hypertension; Isoproterenol; Male; Norepinephrine; Papaverine; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta; Sodium Chloride; Vasodilation | 1988 |
Responses to the beta 2-selective agonist procaterol of vascular and atrial preparations with different functional beta-adrenoceptor populations.
Topics: Adrenergic beta-Agonists; Animals; Aorta; Atenolol; Coronary Vessels; Ethanolamines; Female; Fenoterol; Guinea Pigs; Heart Atria; In Vitro Techniques; Isoproterenol; Male; Muscle Contraction; Muscle, Smooth, Vascular; Norepinephrine; Procaterol; Pulmonary Artery; Rabbits; Rats; Receptors, Adrenergic, beta | 1985 |
The costo-uterine muscle of the rat contains a homogeneous population of beta-adrenoceptors.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Atenolol; Catechols; Electric Stimulation; Epinephrine; Female; Fenoterol; In Vitro Techniques; Isoproterenol; Muscle, Smooth; Norepinephrine; Propanolamines; Rats; Receptors, Adrenergic, beta; Uterus | 1985 |
Pharmacological approaches to the characterization of beta-adrenoreceptor populations in tissues.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Cats; Female; Fenoterol; Guinea Pigs; Male; Muscle Contraction; Myocardial Contraction; Pindolol; Propanolamines; Rats; Receptors, Adrenergic; Receptors, Adrenergic, beta; Reserpine; Species Specificity | 1981 |
The classification of beta-adrenoceptors in isolated ring preparations of canine coronary arteries.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Atenolol; Coronary Vessels; Dogs; Ethanolamines; Female; Fenoterol; In Vitro Techniques; Isoproterenol; Male; Muscle, Smooth, Vascular; Norepinephrine; Procaterol; Receptors, Adrenergic, beta; Serotonin | 1984 |
An homogeneous population of beta 1-adrenoceptors subserves inhibitory responses in guinea-pig ileal preparations.
Topics: Animals; Atenolol; Fenoterol; Guinea Pigs; Ileum; In Vitro Techniques; Isoproterenol; Muscle Contraction; Muscle, Smooth; Propanolamines; Receptors, Adrenergic, beta | 1984 |
Effect of fenoterol on immunological release of leukotrienes and histamine from human lung in vitro: selective antagonism by beta-adrenoceptor antagonists.
Topics: Adrenergic beta-Antagonists; Atenolol; Butoxamine; Ethanolamines; Fenoterol; Histamine Release; Humans; In Vitro Techniques; Leukotriene E4; Lung; Propranolol; SRS-A | 1983 |
Pharmacological evidence for differences in the beta-adrenoceptor populations influencing atrial rate in guinea pig and cat.
Topics: Animals; Atenolol; Cats; Fenoterol; Guinea Pigs; Heart Atria; Heart Rate; Norepinephrine; Propranolol; Receptors, Adrenergic; Receptors, Adrenergic, beta | 1980 |
Combined use of beta-sympathomimetic drugs and beta-blockers during labour.
Topics: Atenolol; Blood Pressure; Ethanolamines; Female; Fenoterol; Heart Rate; Humans; Metoprolol; Obstetric Labor Complications; Pregnancy; Propanolamines; Tachycardia | 1981 |
Extrapulmonary effects of fenoterol and salbutamol in normal subjects.
Topics: Albuterol; Atenolol; Fenoterol; Heart Rate; Humans | 1994 |
Structure-activity relationship studies of (+/-)-terbutaline and (+/-)-fenoterol on beta3-adrenoceptors in the guinea pig gastric fundus.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Atenolol; Bupranolol; Butoxamine; Fenoterol; Gastric Fundus; Guinea Pigs; Male; Muscle Relaxation; Receptors, Adrenergic, beta-3; Structure-Activity Relationship; Terbutaline | 2001 |
Simultaneous separation of eight beta-adrenergic drugs using titanium dioxide nanoparticles as additive in capillary electrophoresis.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Atenolol; Buffers; Celiprolol; Clenbuterol; Electroosmosis; Electrophoresis, Capillary; Fenoterol; Hydrogen-Ion Concentration; Isoproterenol; Metal Nanoparticles; Metoprolol; Propranolol; Reproducibility of Results; Terbutaline; Titanium; Uncertainty | 2008 |
Stereoselective cell uptake of adrenergic agonists and antagonists by organic cation transporters.
Topics: Acebutolol; Adrenergic Agonists; Adrenergic Antagonists; Atenolol; Biological Transport; Fenoterol; Formoterol Fumarate; HEK293 Cells; Humans; Kinetics; Organic Cation Transport Proteins; Organic Cation Transporter 1; Organic Cation Transporter 2; Stereoisomerism | 2020 |